OCC2021-话题@MedSci

#OCC2021#

12篇内容 | 739人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=969506, encodeId=f12296950653, content=<a href='/topic/show?id=10ce1042851a' target=_blank style='color:#2F92EE;'>#OCC2021#</a>, objectTitle=OCC 2021丨变革创新进阶 ——第十五届东方心脏病学会议开幕！, objectType=article, longId=212035, objectId=c85821203549, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20210516/cfb45cecb58d43b1a5e4d389b9b2c5b6.jpg, objectUrl=/article/show_article.do?id=c85821203549, replyNumber=0, likeNumber=73, createdTime=2021-05-29, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c85821203549, moduleTitle=OCC 2021丨变革创新进阶 ——第十五届东方心脏病学会议开幕！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c85821203549)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=969491, encodeId=bf239694910f, content=<a href='/topic/show?id=10ce1042851a' target=_blank style='color:#2F92EE;'>#OCC2021#</a>, objectTitle=OCC 2020 | 云上东方，聚焦泛血管医学, objectType=article, longId=195000, objectId=b40a195000f2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200530/ffef7b12db4141b081be137e82f28203.jpg, objectUrl=/article/show_article.do?id=b40a195000f2, replyNumber=0, likeNumber=79, createdTime=2021-05-29, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b40a195000f2, moduleTitle=OCC 2020 | 云上东方，聚焦泛血管医学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b40a195000f2)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=969286, encodeId=0507969286f6, content=<a href='/topic/show?id=10ce1042851a' target=_blank style='color:#2F92EE;'>#OCC2021#</a>, objectTitle=2021版中国心血管健康指数发布；上海排名第一！, objectType=article, longId=211988, objectId=9669211988ec, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021528/1622204261385_5416545.png, objectUrl=/article/show_article.do?id=9669211988ec, replyNumber=0, likeNumber=48, createdTime=2021-05-28, rootId=0, userName=杜彬, userId=2c4d5497888, projectId=1, avatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9669211988ec, moduleTitle=2021版中国心血管健康指数发布；上海排名第一！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9669211988ec)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=968970, encodeId=7a379689e0f7, content=<a href='/topic/show?id=10ce1042851a' target=_blank style='color:#2F92EE;'>#OCC2021#</a>, objectTitle=OCC 2021：POSITIVE研究结果发布，伊伐布雷定可有效改善我国慢性心衰患者的心率、心功能和生活质量！, objectType=article, longId=211941, objectId=ba39211941c1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021527/1622109010101_92910.png, objectUrl=/article/show_article.do?id=ba39211941c1, replyNumber=0, likeNumber=64, createdTime=2021-05-27, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba39211941c1, moduleTitle=OCC 2021：POSITIVE研究结果发布，伊伐布雷定可有效改善我国慢性心衰患者的心率、心功能和生活质量！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba39211941c1)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=968969, encodeId=18d996896910, content=<a href='/topic/show?id=10ce1042851a' target=_blank style='color:#2F92EE;'>#OCC2021#</a>, objectTitle=OCC 2021：Vascepa®中国临床三期研究结果公布：IPE在中国患者中的有效性和安全性得到进一步证实, objectType=article, longId=211942, objectId=78d22119421d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021527/1622109010101_92910.png, objectUrl=/article/show_article.do?id=78d22119421d, replyNumber=0, likeNumber=60, createdTime=2021-05-27, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78d22119421d, moduleTitle=OCC 2021：Vascepa®中国临床三期研究结果公布：IPE在中国患者中的有效性和安全性得到进一步证实, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78d22119421d)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=968599, encodeId=fc7e968599c5, content=<a href='/topic/show?id=10ce1042851a' target=_blank style='color:#2F92EE;'>#OCC2021#</a> 免费观看所有直播请复制链接打开 http://out.s.medsci.cn/occ/index.html/, objectTitle=OCC2021, objectType=topic, longId=104285, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=56, createdTime=2021-05-26, rootId=0, userName=MedSciZeng, userId=078e1614372, projectId=1, avatar=, status=1, hasArticle=0, attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210526/841e532cda3c46fcb5a678d6669b7bf3.png, type=image, width=750, height=1334)], ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=true, type=1, lengthMark=0)] ms7000002075320390

2021-05-26

(审核中...)

前往app查看评论内容

#OCC2021#

OCC 2021丨变革创新进阶 ——第十五届东方心脏病学会议开幕！

2021-05-29

(审核中...)

前往app查看评论内容

#OCC2021#

OCC 2020 | 云上东方，聚焦泛血管医学

2021-05-29

(审核中...)

前往app查看评论内容

#OCC2021#

2021版中国心血管健康指数发布；上海排名第一！

2021-05-28

(审核中...)

前往app查看评论内容

#OCC2021#

OCC 2021：POSITIVE研究结果发布，伊伐布雷定可有效改善我国慢性心衰患者的心率、心功能和生活质量！

2021-05-27

(审核中...)

前往app查看评论内容

#OCC2021#

OCC 2021：Vascepa®中国临床三期研究结果公布：IPE在中国患者中的有效性和安全性得到进一步证实

2021-05-27

(审核中...)

前往app查看评论内容

#OCC2021# 免费观看所有直播请复制链接打开 http://out.s.medsci.cn/occ/index.html/

2021-05-26

科室
- - 订阅+
  - 更多科室
工具
服务